|
Absin,优宁维旗下自主品牌，您身边的科研百宝箱，作为高品质生命科学产品的中国品牌、生物化学试剂专家，Absin产品涵盖生化试剂、分子生物学、小分子化合物，细胞生物学、免疫学、耗材、产品定制和检测服务等。 越来越多使用我们产品的高分文献发表！发表速度越来越快！ 截止目前，我们检索发现、统计得到的Absin收录的产品文献数量已超4000篇！更多文献在发表中，也欢迎老师们及时提报给我们您的文献发表情况，领取您的文献发表奖励哦! 我们的爆款热卖产品发表文献数量也越来越多，全面优质的产品、总有一款适合您！ 2022年部分文献展示 · Suppression of PFKFB3-driven glycolysis restrains endothelial-to-mesenchymal transition and fibrotic response. (IF 38.104) · Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1. (IF 38.104) · Biomimetic Immunosuppressive Exosomes that Inhibit Cytokine Storms Contribute to the Alleviation of Sepsis. (IF 30.849) · A minimally designed PD-L1-targeted nanocomposite for positive feedback-based multimodal cancer therapy. (IF 26.943) · Anti-alcoholism drug disulfiram for targeting glioma energy metabolism using BBB-penetrating delivery of fixed-dose combination. (IF 20.722) · A Mouse-adapted CVA6 Strain Exhibits Neurotropism and Triggers Systemic Manifestations in a Novel Murine Model. (IF 19.568) · Small-molecule PROTAC mediates targeted protein degradation to treat STAT3-dependent epithelial cancer. (IF 19.456) · Manganese immunotherapy for treating osteosarcoma: Glycosylating 1V209 anchored MnO2 nanosheets prompt pro-inflammatory macrophage polarization. (IF 18.962) · Reprogramming dysfunctional dendritic cells by a versatile metabolism nano-intervenor for enhancing cancer combinatorial immunotherapy. (IF 18.962) · HAp Thermosensitive Nanohydrogel Cavities Act as Brood Pouches to Incubate and Control-Release NSCs for Rapid Spinal Cord Injury Therapy. (IF 18.808) · Engineering micro oxygen factories to slow tumour progression via hyperoxic microenvironments. (IF 17.694) · Phosphorylation of Jhd2 by the Ras-cAMP-PKA(Tpk2) pathway regulates histone modifications and autophagy. (IF 17.694) · A single-cell analysis reveals tumor heterogeneity and immune environment of acral melanoma. (IF 17.694) · Hepatocyte phosphatase DUSP22 mitigates NASH-HCC progression by targeting FAK. (IF 17.694) · Inhibiting 3βHSD1 to eliminate the oncogenic effects of progesterone in prostate cancer. (IF 16.988) · Cytokine nanosponges suppressing overactive macrophages and dampening systematic cytokine storm for the treatment of hemophagocytic lymphohistiocytosis. (IF 16.874) · Prussian Blue Nanoparticles Stabilize SOD1 from Ubiquitination-Proteasome Degradation to Rescue Intervertebral Disc Degeneration. (IF 16.806) · Hypoxia-responsive immunostimulatory nanomedicines synergize with checkpoint blockade immunotherapy for potentiating cancer immunotherapy. (IF 16.744) · Lymphocyte infiltration and thyrocyte destruction are driven by stromal and immune cell components in Hashimoto’s thyroiditis. (IF 14.919) · The E3 ubiquitin-protein ligase Trim31 alleviates non-alcoholic fatty liver disease by targeting Rhbdf2 in mouse hepatocytes. (IF 14.919) · Seamless and early gap healing of osteochondral defects by autologous mosaicplasty combined with bioactive supramolecular nanofiber-enabled gelatin methacryloyl (BSN-GelMA) hydrogel. (IF 14.593) · Verteporfin-mediated on/off photoswitching functions synergistically to treat choroidal vascular diseases. (IF 14.593) · Biomimetic manganese-based theranostic nanoplatform for cancer multimodal imaging and twofold immunotherapy. (IF 14.593) · CD301b+ macrophages mediate angiogenesis of calcium phosphate bioceramics by CaN/NFATc1/VEGF axis. (IF 14.593) · N6-methyladenosine plays a dual role in arsenic carcinogenesis by temporal-specific control of core target AKT1. (IF 14.224) · Impact and microbial mechanism of continuous nanoplastics exposure on the urban wastewater treatment process. (IF 13.4) · Acid-Responsive Aggregated Gold Nanoparticles for Radiosensitization and Synergistic Chemoradiotherapy in the Treatment of Esophageal Cancer. (IF 13.281) · Targeting N7-Methylguanosine tRNA modification blocks hepatocellular carcinoma metastasis after insufficient radiofrequency ablation. (IF 12.91) · Hsa_circ_0000098 is a novel therapeutic target that promotes hepatocellular carcinoma development and resistance to doxorubicin. (IF 12.658) · CircPAK1 promotes the progression of hepatocellular carcinoma via modulation of YAP nucleus localization by interacting with 14-3-3ζ. (IF 12.658) · Mitochondrial calpain-1 activates NLRP3 inflammasome by cleaving ATP5A1 and inducing mitochondrial ROS in CVB3-induced myocarditis. (IF 12.416) · Clusterin negatively modulates mechanical stress-mediated ligamentum flavum hypertrophy through TGF-β1 signaling. (IF 12.153) · Notoginsenoside R1-loaded mesoporous silica nanoparticles targeting the site of injury through inflammatory cells improves heart repair after myocardial infarction. (IF 11.799) · Broad-spectrum and powerful neutralization of bacterial toxins by erythroliposomes with the help of macrophage uptake and degradation. (IF 11.614) · All-stage targeted therapy for the brain metastasis from triple-negative breast cancer. (IF 11.614) · Multi-scale integrative analyses identify THBS2+ cancer-associated fibroblasts as a key orchestrator promoting aggressiveness in early-stage lung adenocarcinoma. (IF 11.556) · AdMSC-derived exosomes alleviate acute lung injury via transferring mitochondrial component to improve homeostasis of alveolar macrophages. (IF 11.556) · CircRNA DDX21 acts as a prognostic factor and sponge of miR‐1264/QKI axis to weaken the progression of triple‐negative breast cancer. (IF 11.492) · SlRBP1 promotes translational efficiency via SleIF4A2 to maintain chloroplast function in tomato. (IF 11.277) 我们秉承踏实, 务实，求精和不断创新的精神为中国科学家提供最好的产品，努力打造属于中国自己的生物试剂品牌！客户文章的集中发表是对我们最大的鼓励和鞭策, 我们将以此为动力，继续埋头苦干, 继续为广大科学家提供更全面更丰富更优质的产品。 |
|
|
